Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Proton Versus Photon Ultrahypofractionated Radiation Therapy and Its Impact on Normal Tissue

NCT05912231 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT05912231
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05912231 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Proton Versus Photon Ultrahypofractionated Radiation Therapy and Its Impact on Normal Tissue
Lead sponsor
Massachusetts General Hospital
Phase
Not applicable
Overall status
Active, not recruiting
Start date
August 15, 2023
Completion date
December 31, 2026
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, breast cancer female, breast cancer stage ii, breast cancer stage iii, myocardial fibrosis